Navigation Links
Intarcia and Quintiles Sign Letter of Intent for Innovative Global Collaboration to Advance ITCA 650 in Type 2 Diabetes
Date:10/21/2011

HAYWARD, Calif., Oct. 21, 2011 /PRNewswire/ -- Intarcia Therapeutics, Inc. today announced the signing of a letter of intent with Quintiles, the world's leading biopharmaceutical services company, to collaborate on the global Phase 3 program for Intarcia's ITCA 650 (DUROS® subcutaneous continuous delivery of exenatide). The program aims to demonstrate multiple advancements in GLP-1 therapy to better address the unmet needs of the almost 350 million people worldwide suffering from Type 2 diabetes – a debilitating and deadly disease. ITCA 650 utilizes a matchstick-size, subcutaneous mini-pump that allows smooth continuous delivery of exenatide from a once-yearly placement. This novel delivery of GLP-1 therapy has been shown to improve HbA1c, weight loss, tolerability and also virtually ensures patient compliance and adherence. By improving the clinical profile and removing the self-injection barrier to use, ITCA 650 would also hold promising potential for use in earlier lines of therapy.

(Logo: http://photos.prnewswire.com/prnh/20050301/SFTU126LOGO)

Upon execution of the definitive agreement, Quintiles will initiate a global Phase 3 program including the six clinical studies that will form the basis of international regulatory submissions. This alliance is the first of a planned two-step partnering strategy, as Intarcia finalizes its late-stage discussions with global pharma companies in the diabetes field. This will form a unique and powerful three-way alliance dedicated to the development and commercialization of ITCA 650 around the world.

"The prospect of a once-yearly, improved GLP-1 therapy could be a game-changer in one of the industry's largest and most rapidly growing therapeutic categories," said Kurt Graves, Executive Chairman of Intarcia's Board of Directors. "P
'/>"/>

SOURCE Intarcia Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Intarcia Therapeutics, Inc. Announces Completion of Enrollment of ITCA 650 Phase 1b Study for the Treatment of Type 2 Diabetes
2. Intarcia Therapeutics Names Kurt Graves Executive Chairman to Advance Strategic Interests and Broaden Commercial Goals
3. Intarcia Presents Positive ITCA 650 Phase 2 Study Results for Type 2 Diabetes at EASD
4. Intarcia Therapeutics Executive Chairman Kurt Graves to Present at 29th Annual JP Morgan Healthcare Conference
5. Intarcia Announces Presentations of Three Clinical Abstracts at the 47th Annual Meeting of the European Association for the Study of Diabetes
6. Intarcia Presents Compelling 48-week Results for ITCA 650 - Data Underlines the Promise to Become the First Injection-free GLP-1 Therapy at the 47th Annual EASD Meeting in Lisbon
7. Dr. Derek Winstanly of Quintiles to Serve as 2009 ACRO Chair; Mr. William Sharbaugh of PPD to Be Chair-Elect
8. Takeda Enters Into Global Strategic Partnerships With Covance and Quintiles
9. Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy
10. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
11. Tone Deafness Explained, from the Harvard Health Letter
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... Jan. 15, 2014 Reportlinker.com announces that ... in its catalogue: ... Analysis http://www.reportlinker.com/p01957812/Insulin-Pump-Market--Forecast-–-Worldwide-Analysis.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Medical_Equipment_and_Supply ... Insulin Pumps are gaining ...
(Date:1/15/2014)... Quebec , Jan. 15, 2014  Valeant Pharmaceuticals International, ... announced that the applicable waiting period under the Hart-Scott-Rodino ... the previously announced tender offer by its indirect wholly-owned ... outstanding shares of common stock of Solta Medical, Inc. ...
(Date:1/15/2014)... , Jan. 15, 2014 Reportlinker.com ... report is available in its catalogue: ... and Technologies for Advanced Drug Delivery ... Administration http://www.reportlinker.com/p01941928/Global-Markets-and-Technologies-for-Advanced-Drug-Delivery-Systems----Focus-on-Routes-of-Administration.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_Delivery_Technology ...
Breaking Medicine Technology:Insulin Pump Market & Forecast - Worldwide Analysis 2Insulin Pump Market & Forecast - Worldwide Analysis 3Insulin Pump Market & Forecast - Worldwide Analysis 4Insulin Pump Market & Forecast - Worldwide Analysis 5Insulin Pump Market & Forecast - Worldwide Analysis 6Insulin Pump Market & Forecast - Worldwide Analysis 7Insulin Pump Market & Forecast - Worldwide Analysis 8Insulin Pump Market & Forecast - Worldwide Analysis 9Insulin Pump Market & Forecast - Worldwide Analysis 10Insulin Pump Market & Forecast - Worldwide Analysis 11Insulin Pump Market & Forecast - Worldwide Analysis 12Insulin Pump Market & Forecast - Worldwide Analysis 13Insulin Pump Market & Forecast - Worldwide Analysis 14Insulin Pump Market & Forecast - Worldwide Analysis 15Insulin Pump Market & Forecast - Worldwide Analysis 16Insulin Pump Market & Forecast - Worldwide Analysis 17Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance For Its Previously Announced Acquisition Of Solta Medical, Inc. 2Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance For Its Previously Announced Acquisition Of Solta Medical, Inc. 3Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 2Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 3Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 4Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 5Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 6Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 7Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 8Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 9Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 10Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 11Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 12Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 13Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 14Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 15Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 16
(Date:4/23/2014)... the potential health benefits of probiotics, antioxidants and other ... And the chemical industry is getting in on the ... deter growth, so the industry is responding with clinical ... cover story in Chemical & Engineering News ... Society. , Melody M. Bomgardner, a senior editor at ...
(Date:4/23/2014)... Washington, April 21, 2014 Five for-profit and ... of $1.25 million in Proof of Concept grants ... ideas into commercial products, the Life Sciences Discovery ... $300,000 Entrepreneur Mentoring Program grant to the Washington ... statewide advisory network to train the next generation ...
(Date:4/23/2014)... Time Physical Activity on Mobility Limitation in Old Age ... risk of mobility limitation in old age, whereas leisure-time ... a study which followed up 5,200 public sector employees ... Gerontology Research Center in Finland and the Finnish Institute ... repetitive, wears the body and lasts for several hours ...
(Date:4/23/2014)... proliferation of endogenous neural precursor cells cannot alone ... From the perspective of neural plasticity, Dr. Yun ... China observed the effects of functional electrical stimulation ... expression of basic fibroblast growth factor and epidermal ... infarct side. The researchers found that functional electrical ...
(Date:4/22/2014)... and industry leaders visited the New Jersey Institute ... Joel S. Bloom for the launch of the ... that provides a new model for business innovation ... education assets and investment. U.S. Senator Cory Booker, ... Joe Taylor, New Jersey Lieutenant Governor Kim Guadagno, ...
Breaking Medicine News(10 mins):Health News:LSDF announces commercialization grants and Entrepreneur Mentoring Program 2Health News:Midlife occupational and leisure-time physical activity limits mobility in old age 2Health News:Government and industry leaders herald launch of NJIT's New Jersey Innovation Institute 2
... Findings from one of the largest cancer chemoprevention trials ever ... or in combination for an average of five and a ... team of researchers coordinated by the Southwest Oncology Group (SWOG) ... D. Anderson Cancer Center and Cleveland Clinic. , Data and ...
... Make Air Healthier to Breathe , , ... Association, a leader in the fight for cleaner air for ... press conference today with Mayor Michael R. Bloomberg and T. ... by Mr. Pickens, the Pickens Plan focuses on reducing America,s ...
... HILLS, Mich., Dec. 9 Some people are not,waiting ... and are taking matters into their own hands, according ... Twenty-seven percent of American adults now ... an online personal health record (PHR) to help,track their ...
... Electronic prescribing (e-prescribing) systems that allow doctors to select ... 100,000 patients per year and possibly more system-wide, according ... Agency for Healthcare Research and Quality. , ... financial implications, the study authors concluded. As e-prescribing systems ...
... As part of its campaign to be the,leading ... Estero,Urgent Care will be hosting "A Matter of Heart" ... Attendees will hear the latest expert,medical advice on heart ... The Estero staff will also be performing,free cholesterol, carotid ...
... Center have identified a region on the human genome that appears to ... prone they are to alcohol abuse. , ... (Vocus) December 9, 2008 ... Center have identified a region on the human genome that appears to ...
Cached Medicine News:Health News:Study finds selenium, vitamin E do not prevent prostate cancer 2Health News:Study finds selenium, vitamin E do not prevent prostate cancer 3Health News:Study finds selenium, vitamin E do not prevent prostate cancer 4Health News:American Lung Association Announces Support of Pickens Plan 2Health News:American Lung Association Announces Support of Pickens Plan 3Health News:American Lung Association Announces Support of Pickens Plan 4Health News:Morpace Reports: Many Likely to Create Own Online Personal Medical Record 2Health News:Study Finds Doctors' Use of E-Prescribing Systems Linked to Formulary Data Can Boost Drug Cost Savings 2Health News:Study Finds Doctors' Use of E-Prescribing Systems Linked to Formulary Data Can Boost Drug Cost Savings 3Health News:Estero Urgent Care to Hold 'A Matter Of Heart' Health Fair, a Free Event Focusing on Heart Disease Prevention to be Held on December 21st at Estero Community Park 2Health News:Genetic Markers Identified for Alcohol Response in UCSF Gallo Study 2Health News:Genetic Markers Identified for Alcohol Response in UCSF Gallo Study 3Health News:Genetic Markers Identified for Alcohol Response in UCSF Gallo Study 4
Ralk Hand Drill, with Jacobs chuck, wrench-locking, with axial channel for Kirschner wires, for twist drills up to 7 mm , for Kirschner wires up to 4 mm...
DeMartel (Bailey) Wire Saw Guide, 33 cm - 13, flexible....
Hudson brace only. Component parts and accessories for Hudson cranial drill....
23 cm - 9, adult size, for skull thickness up to 12 mm....
Medicine Products: